Clinical Efficacy and Safety of Securflux®, an Anti-Reflux Device for Intravenous Infusion
| Autor: | Laura Collantes de Terán, Ferran Barreras, Manuel Cabeza |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Catheter Obstruction law.invention Cohort Studies Randomized controlled trial law Humans Medicine Infusions Intravenous Vascular Patency Aged Aged 80 and over Catheter insertion business.industry Incidence (epidemiology) Graft Occlusion Vascular Reflux Equipment Design Middle Aged Cannula Treatment Outcome Nephrology Anesthesia Venous reflux Female Surgery business Vascular Access Devices Cohort study |
| Zdroj: | The Journal of Vascular Access. 14:77-82 |
| ISSN: | 1724-6032 1129-7298 |
| DOI: | 10.5301/jva.5000095 |
| Popis: | Purpose Catheter obstruction or patency inhibition of the venous access cannula is a frequently experienced problem in patients to whom intravenous (IV) solutions are administered. In this study we assessed the efficacy and safety of Securflux® a disposable device with a back-check valve to prevent reflux in IV infusion sets. Methods A total of 177 adult patients requiring IV medication for at least 24 hours duration were randomized into two groups: with and without the use of Securflux®. Assessments were performed the 10 days after catheter insertion, over three daily visits. The incidence of the onset of reflux (visual/non-visual) and the consequences of reflux for both the patient and healthcare staff were assessed. Results There were 4577 follow-up (study) visits (53.4% in patients with Securflux® and 46.6% without Securflux®). Venous reflux was observed in 14.2% of all visits, more frequently without Securflux® (21.3% vs. 8.1%; PConclusions Securflux® is effective, safe and useful for the prevention of venous reflux onset in patients administered IV medication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|